Tetsuya Yamagata

Co-founder, Chief Scientific Officer

Role
Scientific Advisory, CSO at Modalis Therapeutics
Location
Boston, MA, US
LinkedIn followers
500 followers

Experience

  1. Scientific Advisory, CSO

    Modalis Therapeutics

    Apr 2023 — Present · Boston, MA, US

Education

  • The University of Tokyo

    Doctor of Philosophy (Ph.D.), Hematology/Cancer Biology/Internal Medicine

    1992 — 1996

  • The University of Tokyo

    Doctor of Medicine (M.D.)

    1990

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Tetsuya Yamagata — Scientific Advisory, CSO at Modalis Therapeutics in Boston, MA, US | Unifers